Stocks/RLAY/Filings & Earnings

RLAY SEC Filings, Earnings & Splits

Key events from SEC filings, earnings beat/miss history, stock split records, and share float data for RLAY.

What are RLAY's recent SEC filings?

SCHEDULE 13G · OtherNov 16, 2026

T. Rowe Price Investment Management, Inc. filed a Schedule 13G disclosing beneficial ownership of 17,868,157 shares, or 8.2%, of Relay Therapeutics, Inc. common stock as of September 30, 2026.

View full filing details →
Shares beneficially owned: $17.9M, Percent of class beneficially owned: $8.2
SCHEDULE 13G/A · OtherNov 16, 2026

SoftBank Vision Fund entities filed an amended Schedule 13G reporting beneficial ownership of 21,904,963 shares, or 9.9%, of Relay Therapeutics common stock as of September 30, 2026. The filing is a passive ownership disclosure under Rule 13d-1(d).

View full filing details →
shares beneficially owned: $21.9M, percent of class owned: $9.9
8-K · OtherNov 4, 2026

Relay Therapeutics filed a routine Form 8-K cover page with the SEC on November 4, 2026, containing only standard registrant identification and security information with no substantive corporate event disclosed.

View full filing details →
10-Q · OtherNov 4, 2026

Relay Therapeutics filed its quarterly 10-Q report for the period ending September 30, 2026, reporting 220,959,470 shares of common stock outstanding.

View full filing details →

Has RLAY ever done a stock split?

No stock splits are recorded for RLAY.

What is RLAY's share float?

Public Float
$32.4M
Shares Outstanding
$219.1M
Free Float %
1476.9%

Get Real-Time RLAY Intelligence

SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.

Try SEPT X-Ray Free

More RLAY Research

RLAY FundamentalsRLAY AnalysisSEPT Academy
Share:XRedditFacebookLinkedIn
© SEPT Investing. Filing summaries are extracted automatically from SEC filings and may contain errors. Always verify with official SEC EDGAR filings. Trading involves risk.